Suspect claims in Teva’s suit against Cipla

The US Federal Trade Commission has warned the Israeli drug firm its patents are wrongful as it sues Cipla aggressively

Pharma is getting high on marijuana

As drug companies develop cannabis-based medicines for serious illnesses, generic firms are trying to get into the act

The right pill

Africa will be setting up its first agency to check the spread of spurious drugs

COVID-19 exposes India’s dependence on China for active pharma ingredients

India imports around 90 per cent of APIs used to make antibiotics, says an expert

Second guilty verdict against Monsanto in the US

Federal jury finds that Monsanto’s Roundup herbicide caused a man’s cancer

Centre fails to weed out substandard drugs, reign in prices: Parl panel

It recommends that the government adopt cost of production-based pricing system

COVID-19 also brings focus back on pollution due to pharmaceuticals

No time for quick-fix measures. India needs stricter laws  

15 doctors went on foreign jaunt sponsored by pharma company, says Lok Sabha member

Doctors and pharma company deny charges

COVID-19: Centre brings package to boost bulk drugs

Indian pharma industry is critically dependent on imported raw material 

Pristine Tasmania faces GM threat

Opium industry lobbies to lift moratorium on GM farming

Polluters get away by making ad hoc payment to farmers

No assessment yet of damage caused by industries to villages in Vadodara district

The curious case of Ebola patents

The US government appears to have a cure and (almost) a vaccine for the deadly disease

More give than take in secret trade deals

The tight secrecy over trade negotiations means citizens are not privy to the deals that affect them directly

OxyContin maker Purdue Pharma may settle legal claims with a new ‘public trust’ that would still be dedicated to profit

Two similarly ambitious efforts to build alternatives to the profit-driven pharmaceutical model during and immediately after World War II suggest …

The NATCO CL fallout

The compulsory licence granted to Natco may not be a trendsetter but it will shake up the pharmaceuticals market

Why Americans pay more for prescription drugs than anywhere else globally

The root of the problem is a patent system that allows pharma companies to keep out competition and keep prices sky high

Microplastics all around: A silent epidemic

All types of sea creatures ingest microplastics; as they move up the food chain, the plastic ends up in the human gut

Drugs and cosmetics amendment bill withdrawn from Rajya Sabha

Newer areas like stem cells, regenerative medicines, medical devices and clinical trial cannot be effectively regulated under the existing law, …

Bedaquiline patent win is a half victory

India’s ability to eliminate its huge TB burden by 2025 will be a test of both its patent laws and healthcare policy

Fake medicines are a dangerous threat in Africa: 3 ways to spot them

The most common fakes tend to be the most popular medicines: Painkillers, antibiotics to treat infection, anti-malarials, anti-retrovirals, …

Monsanto's troublesome trait

Bayer is battling seed companies and farmers in several countries over royalty on Monsanto's GM seeds

Evergreening rampant in India

India's patent office has ignored the strict safeguards against evergreening and allowed a flood of secondary drug patents

Memories of a city

Book>> Ahmedabad, Shock city of Twentieth Century India, by Howard Spodek, Orient Blackswan, Rs 795

When Big Pharma has all the answers

IFPMA, the biopharma trade body, has made its claim clear: COVID-19 vaccine management should be left to these handful of companies; and all …

Germany to phase out glyphosate by 2023

The country took this step to protect insect populations that play a pivotal role in ecosystems and pollination of food crops